Atomistry » Chlorine » PDB 6zpd-6zyu » 6zuu
Atomistry »
  Chlorine »
    PDB 6zpd-6zyu »
      6zuu »

Chlorine in PDB 6zuu: Crystal Structure of Thrombin in Complex with COMPOUND30

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND30

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND30:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND30, PDB code: 6zuu was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 43.19 / 1.94
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 69.970, 71.300, 71.860, 90.00, 99.92, 90.00
R / Rfree (%) 16.4 / 21.2

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND30 (pdb code 6zuu). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND30, PDB code: 6zuu:

Chlorine binding site 1 out of 1 in 6zuu

Go back to Chlorine Binding Sites List in 6zuu
Chlorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND30


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND30 within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Cl1001

b:29.9
occ:1.00
CL1 H:QQN1001 0.0 29.9 1.0
C17 H:QQN1001 1.7 27.6 1.0
C16 H:QQN1001 2.7 27.3 1.0
C18 H:QQN1001 2.7 29.5 1.0
O H:PHE227 3.3 23.6 1.0
O H:TRP215 3.3 27.9 1.0
N H:PHE227 3.5 23.4 1.0
N H:TRP215 3.6 28.0 1.0
CG1 H:VAL213 3.6 24.1 1.0
CA H:GLY226 3.6 25.4 1.0
C H:TRP215 3.7 29.6 1.0
N H:SER214 3.9 23.5 1.0
C H:GLY226 4.0 24.5 1.0
C15 H:QQN1001 4.0 28.5 1.0
C19 H:QQN1001 4.0 29.7 1.0
CA H:TRP215 4.1 28.2 1.0
CZ H:TYR228 4.1 23.0 1.0
C H:PHE227 4.1 22.8 1.0
C H:SER214 4.2 26.1 1.0
OH H:TYR228 4.2 24.6 1.0
CB H:ALA190 4.3 26.1 1.0
CE2 H:TYR228 4.3 21.8 1.0
CE1 H:TYR228 4.4 22.9 1.0
N H:GLY216 4.4 29.4 1.0
CA H:PHE227 4.5 23.9 1.0
C20 H:QQN1001 4.5 29.5 1.0
CA H:VAL213 4.6 23.0 1.0
CA H:SER214 4.6 25.7 1.0
C H:VAL213 4.6 23.8 1.0
CB H:VAL213 4.7 23.7 1.0
OD1 H:ASP189 4.8 24.9 1.0
CD2 H:TYR228 4.8 21.5 1.0
CD1 H:TYR228 4.8 22.1 1.0
O H:SER214 4.9 28.6 1.0
O H:HOH1167 4.9 28.6 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Mon Jul 29 18:12:12 2024

Last articles

Cl in 3OC2
Cl in 3OAG
Cl in 3OC1
Cl in 3OBJ
Cl in 3OAD
Cl in 3OB4
Cl in 3OAO
Cl in 3OAF
Cl in 3O6X
Cl in 3O9L
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy